Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The antibody-drug conjugate extended survival by four months compared with chemotherapy.
First-line Lenvima plus Keytruda yields better overall survival for patients with metastatic kidney cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.